-
Latest News
- Achieving symptom relief in patients with ME by targeting the neuro-immune interface & inducing disease tolerance
- Cardiopulmonary responses to exercise in an individual with ME/CFS during long-term treatment with intravenous saline: a case study
- A demon on my life – a play about ME
- Dental considerations for a patient with ME/CFS – a case study
- “Long Haulers” to the rescue? Barrage of Covid-19 media stories, studies & registries spells hope for ME/CFS
Archives
Tag Archives: pharmacogenomics
Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
Treatment avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a split-gender pharmacogenomic study of gene-expression modules, by Mary G Jeffrey, Lubov Nathanson, Kristina Aenlle, Zachary M Barnes, Mirza Baig, Gordon Broderick, Nancy G Klimas, Mary Ann Fletcher, Travis JA Craddock in Clinical … Continue reading →
Posted in News
|
Tagged bioinformatics, Dr Nancy Klimas, drug repositioning, Gordon Broderick, immune dysregulation, immunosuppressants, Kistina Aenlle, Lubov Nathanson, Mary Ann Fletcher, Mary G Jeffrey, Mirza Baig, pharmacogenomics, Travis JA Craddock, treatments, Zachary Barnes
|
Comments Off on Treatment avenues in ME/CFS: a split-gender pharmacogenomic study of gene-expression
